Clinical Trials Logo

Clinical Trial Summary

Studying subjects with HbA1C tests >10 and no follow-up test within 6 months and appointments scheduled in the next 60 days from data run date. Subjects who receive intervention message may be more likely to follow up with their provider to schedule a follow up HbA1C test.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04869319
Study type Observational
Source NYU Langone Health
Contact
Status Completed
Phase
Start date July 13, 2020
Completion date March 28, 2024

See also
  Status Clinical Trial Phase
Completed NCT03816514 - Noninvasive Hemoglobin Monitoring for Maintaining Hemoglobin Concentration Within the Target Range N/A
Completed NCT02722759 - Haemoglobin Measurement for Babies N/A
Completed NCT01529502 - Pilot Study About the Harmful Effects of Blood Storage on Overweight People and the Role of iNO in This Setting Phase 2
Terminated NCT00210795 - A Phase II Study to Assess Changes in Physical Function in Elderly Patients With Chronic Anemia Phase 2
Terminated NCT00228995 - A Phase II Study to Assess Changes in Physical Function in Elderly Patients With Chronic Anemia Phase 2
Recruiting NCT04189250 - Comparison of the Automatized and the Optimized Carbon Monoxid Rebreathing Protocol N/A
Completed NCT02876627 - Effect Aerobic Training on Women With Breast Cancer After Chemotherapy Phase 1
Completed NCT02655107 - Non-invasive Measurement of Hemoglobin in Infants and Neonates N/A
Terminated NCT00246597 - A Phase III Clinical Trial of PROCRIT (Epoetin Alfa) Versus Placebo in Women Undergoing Adjuvant Chemotherapy for Stage I, II or III Breast Cancer Phase 3
Completed NCT05506748 - Association Between Preoperative HALP and Immediate Postoperative Outcomes